Share Price:

APNASPENAspen Pharmacare Hldgs10003-68 (-0.68%)
Our Response to Covid
Country Sites

Day: August 31, 2022

Aspen delivers double digit organic growth in normalised EBITDA, operating profit and earnings

Johannesburg – JSE-listed Aspen Pharmacare Holdings Limited (APN), a global multinational specialty pharmaceutical company, is pleased to report reviewed provisional Group financial results for the year ended 30 June 2022.   SALIENT FEATURES Revenue from continuing operations increased by 2% (+5% in constant exchange rate (“CER”)) to R38,6 billion (FY2021: R37,8 billion); Normalised EBITDA from… Continue reading Aspen delivers double digit organic growth in normalised EBITDA, operating profit and earnings

Aspen concludes a collaboration agreement to manufacture and make available four Aspen-branded vaccines for Africa.

Durban, South Africa – JSE Limited listed Aspen Pharmacare Holdings Limited (APN), a global multinational specialty pharmaceutical company, is pleased to announce that one of its wholly-owned South African subsidiaries, Aspen SA Operations (Pty) Limited (“Aspen SA Operations”), has concluded a ten-year agreement (“the Agreement”) with Serum Institute of India Pvt Ltd (“the Serum Institute”), the world’s largest vaccine producer,… Continue reading Aspen concludes a collaboration agreement to manufacture and make available four Aspen-branded vaccines for Africa.

Our Purpose

Find out more
To improve the health and quality of life of patients.

Our Vision

Find out more
To deliver value to all our stakeholders as a responsible corporate citizen that provides high-quality, affordable medicines globally.

Our Values

Find out more
Define the foundation on which Aspen has been built. These are the values we share as we work together toward achieving the vision of the Group.
aspen-holdings-logo-white-img

Aspen Holdings
www.aspenpharma.com
Hotline (South Africa)
0800 122 912

Medical Careline (South Africa) 0800 118 088

Facebook-f Twitter-square Instagram Linkedin

About Aspen

We Care

Careers

Contact Us

ASPEN PHARMACARE HOLDINGS LTD: Switchboard: +27 31 580-8600

Aspen Place, 9 Rydall Vale Park
Douglas Saunders Drive, La Lucia Ridge South Africa

P.O. Box 25125, Gateway, Kwa‑Zulu Natal, 4321, South Africa

Closed Period

Aspen is in a closed period from 1 January until the publication of our interim results on the JSE SENS platform scheduled to be released on 1 March 2023.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.